Literature DB >> 31794216

Rational Design of Chymotrypsin Inhibitor 2 by Optimizing Non-Native Interactions.

Fernando B da Silva1, Vinícius M de Oliveira2, Murilo N Sanches1, Vinícius G Contessoto3,4, Vitor B P Leite1.   

Abstract

Rational design of proteins via mutagenesis is crucial for several biotechnological applications. A significant challenge of the computational strategies used to predict optimized mutations is to understand the influence of each amino acid during the folding process. In the present work, chymotrypsin inhibitor 2 (CI2) and several of its designed mutants have been simulated using a non-native hydrophobic and electrostatic potential as a structure-based Cα model. Through these simulations, we could identify the most critical folding stage to accelerate CI2 and also the charged residues responsible for providing its thermostability. The replacement of ionizable residues for hydrophobic ones tended to promote the formation of the CI2 secondary structure in the early transition state, which speeds up folding. However, this same replacement destabilized the native structure, and there was a decrease in the protein thermostability. Such a simple method proved to be capable of providing valuable information about thermodynamics and kinetics of CI2 and its mutations, thus being a fast alternative to the study of rational protein design.

Mesh:

Substances:

Year:  2019        PMID: 31794216     DOI: 10.1021/acs.jcim.9b00911

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  1 in total

1.  Electrostatic interaction optimization improves catalytic rates and thermotolerance on xylanases.

Authors:  Vinícius de Godoi Contessoto; Felipe Cardoso Ramos; Ricardo Rodrigues de Melo; Vinícius Martins de Oliveira; Josiane Aniele Scarpassa; Amanda Silva de Sousa; Letıcia Maria Zanphorlin; Gabriel Gouvea Slade; Vitor Barbanti Pereira Leite; Roberto Ruller
Journal:  Biophys J       Date:  2021-04-05       Impact factor: 3.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.